We are live on ! Find out more
NKGNW

NKGen Biotech, Inc. Warrants
NKGNW

Delisted

NKGNW was delisted on the 4th of March, 2025.

Back to rankings

38 hedge funds and large institutions have $1.43M invested in NKGen Biotech, Inc. Warrants in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

19% more funds holding

Funds holding: 32 → 38 (+6)

6% less capital invested

Capital invested by funds: $1.52M → $1.43M (-$96.5K)

Holders
38
Holders Change
+6
Holders Change %
+18.75%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
4
Reduced
2
Closed
2
Calls
$15K
Puts
–
Net Calls
+$15K
Net Calls Change
+$8K

Top Buyers

Rank Fund Capital Flow
1
RCM
Rivernorth Capital Management
Florida
+$41.1K
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$12.6K
3
Jane Street
Jane Street
New York
+$8.41K
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$5.04K
5
ETH
Exos TFP Holdings
New York
+$4.2K

Top Sellers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
-$29K
2
FTCM
Fir Tree Capital Management
New York
-$7K
3
GF
Gabelli Funds
New York
-$3.36K
4
FBCM
Fort Baker Capital Management
California
-$1.55K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$1.19M – – –
RCM
2
Rivernorth Capital Management
Florida
$52.2K +$41.1K +489,751 +300%
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$15.4K – – –
BNP Paribas Financial Markets
4
BNP Paribas Financial Markets
France
$12.7K +$12.6K +150,000 New
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$11.9K +$5.04K +60,000 +75%
AA
6
AQR Arbitrage
Connecticut
$11.1K – – –
DCM
7
Difesa Capital Management
New York
$10.2K +$892 +10,623 +10%
PC
8
Periscope Capital
Ontario, Canada
$10.2K – – –
Jane Street
9
Jane Street
New York
$8.5K +$8.41K +100,165 New
6CM
10
683 Capital Management
New York
$8.49K – – –
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
11
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$8.49K – – –
KL
12
KIM LLC
Kansas
$8K – – –
KC
13
Kepos Capital
New York
$7K – – –
PSAMP
14
P. Schoenfeld Asset Management (PSAM)
New York
$6.79K – – –
TCA
15
Taconic Capital Advisors
New York
$5.94K – – –
PAMP
16
Polar Asset Management Partners
Ontario, Canada
$5.09K – – –
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$4.25K – – –
ETH
18
Exos TFP Holdings
New York
$4.25K +$4.2K +50,000 New
SCM
19
Shaolin Capital Management
Florida
$4K – – –
SG
20
StoneX Group
New York
$3.48K +$3.45K +41,029 New
AIMCA
21
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$3.4K – – –
FBCM
22
Fort Baker Capital Management
California
$3.14K -$1.55K -18,464 -33%
MTCM
23
Mint Tower Capital Management
Netherlands
$3K +$3.36K +40,000 New
JFG
24
Jefferies Financial Group
New York
$2.97K +$2.94K +35,000 New
SCM
25
Saba Capital Management
New York
$2.72K – – –
1
2

NKGNW Hedge Fund Activity: Q4 2022 in Review

38 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q4 2022, worth a combined $1.43M — down 6.3% from $1.52M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new NKGNW positions and 2 closed out — a net gain of 7 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Rivernorth Capital Management, adding an estimated $41.1K. The largest seller was Magnetar Financial, exiting entirely with an estimated $29K sold.

  • 38 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q4 2022, up from 32 in Q3 2022.
  • Funds reported $1.43M of NKGen Biotech, Inc. Warrants stock for Q4 2022, down 6.3% quarter-over-quarter.
  • 9 funds opened new NKGen Biotech, Inc. Warrants positions in Q4 2022 and 2 closed out, a net change of +7 holders.
  • The largest NKGen Biotech, Inc. Warrants buyer in Q4 2022 was Rivernorth Capital Management, an estimated $41.1K added.
  • The largest NKGen Biotech, Inc. Warrants seller in Q4 2022 was Magnetar Financial, an estimated $29K sold.

Based on aggregated 13F filings for Q4 2022.